"IF" orBec is rejected. (may I repeat, that is ONLY an "IF") unless the panel outright trashed DORB, I would think that SOMEONE would step up to the plate and make an offer. I also believe it would be HIGHER than the current price. How much is anyones guess. The next question would be, is how long before that offer was made.
but that is getting a bit ahead of things. let's see what the panel has to say today before looking at the other possibilities.
I am a bit concerned that the DNDN and IDMI panel review did not go well. Of course their data is worse then DOR's in the first place, but with the big pharma board, it is not looking good for little DORB. One can only have hope now, but the odds are against us not for the data but for the panel and their ties to big pharma. DOR will have to either get the Tau partnership sealed or look for a big pharma player, or both. The little guy just doesn't have a chance with everything one sided. But again we can hope.